Categories Earnings, LATEST, Other Industries

Earnings Preview: Key brands could fuel Pfizer’s Q3 revenues

Pfizer Inc. (PFE) is scheduled to report earnings results for the third quarter of 2018 on Tuesday, October 30, before market opens. Wall Street anticipates earnings of $0.76 per share on revenue of $13.5 billion, reflecting year-over-year increases of 13.4% and 2.6%, respectively.

The company has consistently topped estimates in the past four quarters and is on track to do the same in the to-be-reported quarter as well. For the second quarter, Pfizer reported better-than-expected results for both the top and bottom lines. Revenues rose 4% to $13.5 billion while EPS improved 21% to $0.81 per share.

The second-quarter revenue growth was driven by the strong performance of key brands such as Xeljanz, Ibrance and Eliquis, and this momentum is expected to continue in the third quarter. New approvals for some products is also expected to help push the topline higher. The company’s cost reduction efforts are likely to reflect positively on the bottom line.

Pfizer stock falls on weak revenue outlook

However, last quarter, Pfizer was hurt by loss of exclusivity for certain products, sales declines in legacy Established Products and legacy Hospira supply shortages. Stiff competition continues to put pressure on the sales and market share of some of Pfizer’s products and the impact from these competitive pressures is a point worth keeping an eye on in the third quarter report.

On October 1, Pfizer announced that COO Albert Bourla will succeed Ian Read as CEO at the beginning of 2019. Read will move on to the new role of Executive Chairman next year. Pfizer is likely to see new strategies and changes in the near future, which will be worth watching.

Pfizer’s shares have climbed 18% so far this year but looking at the past one month, the stock is down 2%. As of 11:40 am ET, the stock is down 1.5%.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Earnings calendar for the week of March 8

On the heels of lawmakers moving closer to passing the stimulus bill, inflations concerns gripped the market after Federal Reserve chief Jerome Powell at a meeting said the reopening would

Why Costco’s (COST) growth prospects might depend on beating costs, digital lag

Though the retail boom triggered by the pandemic was estimated to be short-lived initially, the shopping spree continued as customers stocked up on essential items, concerned about the persistent market

Gap (GPS) hopes to see a favorable recovery by the second half of 2021

Shares of Gap Inc. (NYSE: GPS) were up 5.8% in afternoon hours on Friday. The stock has gained 103% over the past 12 months. Gap reported mixed results for the

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top